IMMUNE PHARMACEUTICALS INC
IMMUNE PHARMACEUTICALS INC (IMNP) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 30 transactions totaling $2.1M, demonstrating a bullish sentiment with $2.1M in net insider flow. The most recent transaction on May 22, 2018 involved a purchase of 25,000 shares valued at $6.0K.
IMNP Insider Activity Summary
Who Is Buying IMNP Stock?
No significant insider buying has been recorded for IMNP in the recent period.
Who Is Selling IMNP Stock?
No significant insider selling has been recorded for IMNP in the recent period.
Is IMMUNE PHARMACEUTICALS INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for IMNP is bullish with an Insider Alignment Score of 100/100 and a net flow of $2.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
IMNP Frequently Asked Questions
Understanding IMNP Insider Activity
Insider trading at IMMUNE PHARMACEUTICALS INC (IMNP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading IMNP stock, having executed 30 transactions in the past 90 days. The most active insider is Daniel Gedeon Teper (Executive), who has made 14 transactions totaling $1.0M.
Related Tools
Track IMMUNE PHARMACEUTICALS INC Insider Activity
Get notified when executives and directors at IMNP file new Form 4 transactions